Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Cancers|September 9, 2023
Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable MetricsSouzana Logotheti, Eugenia Papadaki, Vasiliki Zolota, et al.
Revista Espanola De Enfermedades Digestivas|December 29, 2020
Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the liverAna Aparicio Serrano, Javier Castro Rodríguez, Elma Gallego Jiménez, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|July 9, 2018
EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancersRama Soundararajan, Anurag N Paranjape, Sankar Maity, et al.
European Urology|July 14, 2019
Prostate Cancer: Quo Vadis?Christopher J Logothetis, Ana Aparicio, Filippos Koinis, et al.
Cancer Letters|January 16, 2002
Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207Artur Plonowski, Andrew V Schally, Attila Nagy, et al.
Science Translational Medicine|April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancerSumit K Subudhi, Luis Vence, Hao Zhao, et al.
Journal of the National Medical Association|December 30, 2004
Prognostic factors for survival among Caucasian, African-American and Hispanic men with androgen-independent prostate cancerReena B Wyatt, Ricardo F Sánchez-Ortiz, Christopher G Wood, et al.
Revista Espanola De Enfermedades Digestivas|August 24, 2021
Malignancy of intraductal papillary neoplasm of the bile ductAna Aparicio Serrano, Alberto Gómez Pérez, Javier Manuel Zamora Olaya, et al.
The Journal of Urology|November 11, 2005
Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancerDan Leibovici, Ashish M Kamat, Curtis A Pettaway, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2008
CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patientsChrysoula I Liakou, Ashish Kamat, Derek Ng Tang, et al.
Pageof 20